Daniel Ramsbeck

Also affiliated with Anhalt University of Applied Sciences, Dechra Pharmaceuticals (United Kingdom), Fraunhofer Institute for Cell Therapy and Immunology

Biochemistry, Genetics and Molecular BiologyDentistryMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis”.

Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.100263

N/A

0DataRank · unranked

18 citations

Miriam Linnert, Jens‐Ulrich Rahfeld, Anke Piechotta, Daniel Ramsbeck, Mirko Buchholz +10 more

Prefusion-specific antibody-derived peptides trivalently presented on DNA-nanoscaffolds as an innovative strategy against RSV entry

Frontiers in Virology(2022)10.3389/fviro.2022.994843

N/A

0DataRank · unranked

5 citations

Christin Möser, Christian Jäger, Basma Altattan, Daniel Ramsbeck, Martin Kleinschmidt +4 more

Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers DS-103 as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.4c02373

N/A

0DataRank · unranked

13 citations

Lukas Biermann, P. R. Watson, Jingyu Li, Beate König, Matthew N. Gaynes +11 more